Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2015-03-31 to 2021-05-31
Current total value of award: $11911993.55
Description: DE-OBLIGATE CANCELING FUNDS.